Both Melanoma and Renal Cell Carcenoma are also orphan drug candidates. They have to go for their best prospects. Resources are limited. As they stated in the announcement "mesothelioma, non small cell lung cancer and colorectal cancer are strong alternative activity trial targets; and each may be the subject of supplementary activity trials at a later date"
With so many possible targets they have to start somewhere. I think it is a shame they havnt had more govt support for a mesothelioma trial.
- Forums
- ASX - By Stock
- SBP
- solbec ann phase 2 targets
SBP
solbec pharmaceuticals limited
solbec ann phase 2 targets, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)